Elizabeth Holmes, founder of catastrophically failed blood testing startup Theranos, will face trial next year , with jury selection slated for July 28, 2020 and the trial itself slated for following August, by TechCrunch.
Holmes and ex-Theranos president Ramesh "Sunny" Balwani have been indicted on 1
Theranos and its principals raised over $ 700 million (and achieved a $ 9 billion valuation) in the Securities and Exchange Commission later on with "elaborate, years-long fraud in which they exaggerated or made false statements about the company's technology, business , and financial performance. ”While Holmes settled with the SEC in a civil fraud case, Balwani is fighting both cases
According to Bloomberg, Holmes is apparently planning on fighting the charges on going after John Carryrou, the Wall Street Journal reporter who revealed many of the most damaging details about Theranos in a series of articles and characterized the company's conduct as unethical and unauthorized experimentation on patients. Pre-trial information sharing with prosecutors shows that Holmes' attorneys have "unearthed Carreyrou's early contacts with New York state regulators and various federal agencies" as well as with a doctor in Arizona, apparently in an attempt to paint regulators as unduly influenced by an unethical journalist eager to damage Theranos:
Holmes is pushing prosecutors to about every communication they are aware of because Carreyrou "goes beyond reporting the Theranos story," here lawyers said in a court filing. He prodded to lodge complaints about the company with regulators, and then went to pursue the complaints, according to the filing.
“The jury should be aware that an outside actor, eager to break a story, and portray the story as a work of investigative journalism, exerting influence on the regulatory process was found to have warped the agencies 'focus on the company and possibly biased the agencies' findings against it, ”attorneys wrote. "The agencies' interactions with Carreyrou thus go to the heart of the government's case."
Bloomberg noted that legal experts say this kind of defense generally seems to pop up in cases where prosecutors have a strong case and could be an attempt to find "a single juror sympathetic to the idea that government agencies were in cahoots with Carreyrou and overzealous in their pursuit." Prosecutors in turn have insisted that they did not interview or request documents from Carryrou or anyone else from the Journal, Bloomberg wrote, and that they were not aware of any interactions between Carryrou and agencies involved in the case outside of inquiries he placed via “emails and voicemails.”
“If I were the government, I would argue that none of this is relevant, and it is likely to distract the jury from the real issue in the case, "said Barbara McQuade. “The case is about the conduct of Theranos, not Carreyrou.”
Holmes, who before her indictment was reportedly overconfident she was mulling starting another company, seems to have her work cut out for here. On Friday, the Journal also reported that prosecutors said they gave the defense over two million pages of evidence and plan on turning over more; one of Holmes' attorneys, Kevin Downey, complained that "I don't even know what a gigabyte or data is. My guess is if you print it out it would fill up this entire room. ”